Distinct differences in the profiles of reactive hypermmia have been demonstrated by ECGtriggered plethysmography, between healthy normal subjects and untreated patients with intermittent claudication (Verhaegen et al. 1976 ). These workers reported that claudicating subjects showed a decreased blood flow and a diminished vascular responsiveness after ischaemia. The same method was therefore used to study the nature and magnitude of change in hyperemic flow under open standardized conditions after repeated administration of cinnarizine.
PATIENTS AND METHODS

Patients
Twenty-four patients (17 males and 7 females, age range 44-78 years) presenting with stable phase intermittent claudication were studied, the diagnosis having been confirmed radiographically. All previous vasoactive medications had been withdrawn during the previous 4 weeks. Their relevant clinical data are given in Table 1. Trial Design Blood flow measurements were made using the Janssen Scientific Division semi-continuous venous occlusion plethysmograph as described earlier (Verhaegen et al. 1976 ). Measurements were made at entry and after 3 months of administration of cinnarizine in a total daily dosage of 225 mg (75 mg capsules three times daily). Prior to testing, each subject was rested for 10 min in the supine position in a room maintained at constant temperature (22-24°C).
Plethysmography
Mercury-filled silicone rubber strain gauges were positioned on the calf of the more badly affected limb and a blood pressure cuff, which could be inflated with air under constant pressure, was placed over the femoral artery. With this automated technique, flow measurements could be made during every cycle of 5 heart beats (each cycle comprising venous occlusion for 3 beats, followed by a pressure-free interval of 2 heart beats). Resting flow (FR) was determined from the average of 30 consecutive cycles and expressed as ml/100 ml flow units. Reactive hyperemia was induced by a programmed 3 min of arterial occlusion by inflating thecuffto 260 mmHg, after whichsemi-continuous venous occlusion plethysmography was automatically resumed. From the curves obtained, the following measurements were made: resting flow (FR) and the peak flow after 3 min of arterial occlusion (FP3); time (sec) to peak flow (TFP3); time (sec) to 50 % loss of peak flow (T1) and the total duration (sec) of reactive hyperwmia (TT).
Results
The plethysmographic findings before and after cinnarizine treatment are shown in Table 2 and Fig 1, together with the results of statistical analysis by paired Student's t test. Table 3 shows the individual plethysmographic responses to Table 3 Individual plethysmographic respons to cinnarizine treatment (n = 24)
No. ofpatients Mean resting flow was not significantly by cinnarizine, whereas peak flow was in by 20% (P<0.01), with 16/24 patients sho increase. The remainder either showed a c (6) or were unchanged (2). Mean time I flow was reduced by 25 % (P<O.01) with 2 24 patients demonstrating a decrease. fr was also reduced by approximatel) (P<0.01) with 19 patients showing a d Data on the total time of hypermmia coulh analysed statistically because quantitati points were not obtained in all patiel examination of the individual results revea this was increased in 16 patients, decreas and unchanged in 1.
Discussion T Y2
The hyperemic response patterns before treatment showed evidence of a decreased blood flow and diminished vascular responsiveness when these results are compared with previous values in normal subjects using the same technique (Verhaegen et al. 1976) . This has also been demonstrated by others, employing both plethysmographic methods (Linhart et al. 1974 , Hillestad 1963 and isotopic clearance techniques (Lassen 1964) . The finding of a 20% increase in peak blood flow after hypermmia and a significant shortening of TPF and Ti after cinnarizine suggests that there is hmmodynamic improvement in vessel reactivity, making them approximate more closely to normal healthy vessels. The significance of the lengthening of the total duration of reactive hyperwmia in 66 % of cases is not easily explained. However, the resulting increase in the area under the curve, indicating restitution of the deficit incurred during occlusion, may indicate that the ischemic limbs have derived greater metabolic benefit from blood sequestered in the tissues during occlusion, independently of flow changes. These results are in agreement with previous studies showing that cinnarizine has a clear action on peripheral vascular reactivity. This marked enhancement of post-isch2mic blood flow has also been shown in healthy subjects (Jageneau et al. 1974 ) and in claudicating patients (Verhaegen et aL 1974) . In clinical terms these h:modynamic improvements have been shown to benefit the patient with peripheral circulatory disorders by relieving symptoms and improving exercise tolerance (Schuermans et al. 1971 
Summary
Twenty-four patients with stable intermittent claudication were treated with cinnarizine (75 mg three times daily) for 3 months. The results were assessed by plethysmography using ECG triggering to allow semi-continuous measurement of blood flow following a 3 min period of arterial occlusion. After treatment, cinnarizine did not modify resting blood flow but significantly increased calf blood flow during post-ischmmic reactive hyperamia. Cinnarizine also significantly shortened the time to peak flow and the 50% decay time. The total duration of reactive hyperemia was increased in 66 % of patients.
These results show that cinnarizine increases peripheral arterial reactivity in diseased vessels and facilitates blood flow following periods of ( . . I . tissue ischaemia. The increase in blood flow provides a rationale for its efficacy in the treatment of circulatory insufficiencies.
